Skip to main content
TipRanks
Go Ultimate75% OFF

Bausch Health Companies (BVF) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

BVF Analyst Ratings

Hold
3Ratings
0Buy3Hold0Sell
Based on 3 analysts giving stock ratings to Bausch Health Companies in the past 3 months

BVF Stock 12 Month Forecast

€8.06▲(11.22% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is EUR 8.06 with a high forecast of EUR 8.95 and a low forecast of EUR 7.16. The average price target represents a 11.22% change from the last price of EUR 7.25.
Highest Price Target€8.95Average Price Target€8.06Lowest Price Target€7.16

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:BVF
Price TargetArticle
Barclays€6.27→€8.06hold11.22%UpsideReiterated11/11/26
RBC Capital€8.95hold23.58%UpsideReiterated10/29/26
Jefferies€5.82→€7.16hold-1.13%DownsideReiterated10/29/26
Oppenheimer―hold―Reiterated05/01/26
Evercore ISI―hold―Reiterated04/30/26
TD Cowen€6.27hold-13.49%DownsideReiterated04/30/26
Bank of America Securities€4.48sell-38.21%DownsideReiterated02/18/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
SLDBSolid Biosciences
RDNTRadnet
PTGXProtagonist Therapeutics
HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bausch Health Companies

3 Months
Jason Gerberry
Jason GerberryBank of America Securities
Success Rate4/9 ratings generated profit
44%
Average Return
-8.13%

Copying Jason Gerberry's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -8.13% per trade.

1 Year
Jason Gerberry
Jason GerberryBank of America Securities
Success Rate5/9 ratings generated profit
56%
Average Return
-2.71%

Copying Jason Gerberry's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of -2.71% per trade.

2 Years
Jason Gerberry
Jason GerberryBank of America Securities
Success Rate5/9 ratings generated profit
56%
Average Return
-0.54%

Copying Jason Gerberry's trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of -0.54% per trade.

BVF Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for BVF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold43245
Sell00000
Strong Sell00000
total43245

In the current month, BVF has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. BVF average Analyst price target in the past 3 months is 8.06.

BVF Financial Forecast

€-1€-0.25€0.5€1.25€2Q1 2026Q3 2026Q4 2026
High€1.32
Consensus€1.22
Low€1.09

BVF Earnings Forecast

Next quarter’s earnings estimate for BVF is EUR 1.22 with a range of EUR 1.09 to EUR 1.32. The previous quarter’s EPS was EUR 1.57. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€2.2B€2.3B€2.4B€2.5B€2.6BQ1 2026Q3 2026Q4 2026
High€2.47B
Consensus€2.47B
Low€2.46B

BVF Sales Forecast

Next quarter’s sales forecast for BVF is EUR 2.47B with a range of EUR 2.46B to EUR 2.47B. The previous quarter’s sales results were EUR 2.61B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

BVF Stock Forecast FAQ

What is DE:BVF’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch Health Companies’s 12-month average price target is €8.06.
What is DE:BVF’s upside potential, based on the analysts’ average price target?
Bausch Health Companies has 11.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bausch Health Companies a Buy, Sell or Hold?
Bausch Health Companies has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is Bausch Health Companies’s share price target?
The average share price target for Bausch Health Companies is €8.06. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €8.95, and the lowest forecast is €7.16. The average share price target represents a 11.22% increase from the current price of €7.245.
What do analysts say about Bausch Health Companies?
Bausch Health Companies’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Bausch Health Companies?
To buy shares of DE:BVF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.